24-Week jumping exercise influence on growth speed and GH-IGF-1-IGFBP-3 axis among short-stature children
- PMID: 40597964
- PMCID: PMC12219976
- DOI: 10.1186/s12887-025-05821-3
24-Week jumping exercise influence on growth speed and GH-IGF-1-IGFBP-3 axis among short-stature children
Abstract
Objective: To explore the effect of jumping exercises on improving short-stature symptoms and changes of serum GH, IGF-1, IGFBP-3, and IGF-1/IGFBP-3 in short-stature patients, so as to provide potential theoretical reference for short-stature treatment.
Methods: A non-randomized controlled intervention study was registered on January 8, 2025, with the China Clinical Trial Registry (ChiCTR2500095544). This study was conducted with the recruitment of 15 short-stature children in the same environment (Exercise Experimental Group 1); 20 children with normal development level (Blank Control Group 2); and 27 healthy short-stature children in this area (Short Blank Control Group 3). Children in Group 1 were given exercise intervention for 24 weeks, and those in the other two groups were provided with natural observation for 24 weeks. After the experiment, this study further analyzed the growth values of height, growth hormone (GH), insulin-like growth factor-1 (IGF-1), insulin-like growth factor-binding protein 3 (IGF-BP-3) and IGF-1/IGF-BP-3 of the three groups.
Results: After 24 weeks of exercise intervention, Group 1 had higher height, serum IGF-1, and the growth value of molar ratio of IGF-1/IGFBP-3 than those of Group 2 and Group 3, with statistically significant difference between Group 1 and Group 3 (all p < 0.05). However, there was no significant difference in serum GH level and its growth value among groups before and after the experiment (p > 0.05),. In addition, the serum IGFBP-3 in Group 1 was lower than that in Group 2 and Group 3 (both p < 0.01).
Conclusion: The 24-week jumping exercise intervention can effectively improve the height of short-stature children. It can enhance the function of GH-IGF-1-IGFBP-3 axis through improving serum IGF-3 level and molar ratio of IGF-1/IGFBP-3, while decreasing the level of serum IGFBP-3. Nevertheless, exercise intervention has no effect on morning GH secretion in short-stature children.
Keywords: Exercise to improve height; GH; IGF-1; IGFBP-3; Molar ratio of IGF-1/IGFBP-3; Short-stature.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study is in line with and follows the Declaration of Helsinki.The studies involving humans were approved by Ethics Committee of the Shanghai University of Sport (No. 102772023RT137). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.Clinical registration number is ChiCTR2500095544. The registration date is January 8, 2025. For subjects under the age of 16, we have obtained the consent of their parents or legal guardians before conducting the test. Their parents or legal guardians, as well as participants in the study, have given their consent for the test information to be published. All experimental procedures complied with relevant ethical standards and guidelines. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3. Cochrane Database Syst Rev. 2016. PMID: 27030386 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Growth hormone therapy for people with thalassaemia.Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012284. doi: 10.1002/14651858.CD012284.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 May 28;5:CD012284. doi: 10.1002/14651858.CD012284.pub3. PMID: 28921500 Free PMC article. Updated.
-
Cord blood levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 correlate with perinatal brain development in fetal congenital heart disease.Ultrasound Obstet Gynecol. 2025 Aug;66(2):200-209. doi: 10.1002/uog.29271. Epub 2025 Jun 28. Ultrasound Obstet Gynecol. 2025. PMID: 40580544 Free PMC article.
-
Recombinant growth hormone for idiopathic short stature in children and adolescents.Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004440. doi: 10.1002/14651858.CD004440.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636758
References
-
- Chen XJ, Liu DY, et al. Analysis of the prevalence of short stature in children in three cities in Anhui Province. Chin J Children’s Health. 2017;25(4):5. 10.11852/zgetbjzz2017-25-04-23.
-
- Tenuta MC et al. FrancescoCangiano (2021) Somatotropic-Testicular Axis: A crosstalk between GH/IGF-I and gonadal hormones during development, transition, and adult age.Andrology 2021, 9(1). - PubMed
-
- Inzaghi E, Reiter E, Cianfarani S. The challenge of defining and investigating the causes of idiopathic short stature and finding an effective therapy. Hormon Res Pediatr. 2019;92(2):1–13. 10.1159/000502901. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous